LUTONIX® 035 Drug Coated Balloon PTA Catheter, Model 9010

Drug-coated Peripheral Transluminal Angioplasty Catheter

FDA Premarket Approval P170003

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the lutonix® 035 drug coated balloon pta catheter. This device is indicated for percutaneous transluminal angioplasty (pta), after pre-dilatation, for the treatment of stenotic lesions in dysfunctional native arteriovenous dialysis fistulae that are 4 mm to 12 mm in diameter and up to 80 mm in length.

DeviceLUTONIX® 035 Drug Coated Balloon PTA Catheter, Model 9010
Classification NameDrug-coated Peripheral Transluminal Angioplasty Catheter
Generic NameDrug-coated Peripheral Transluminal Angioplasty Catheter
ApplicantLUTONIX
Date Received2017-01-23
Decision Date2017-08-25
Notice Date2017-09-08
PMAP170003
SupplementS
Product CodePRC
Docket Number17M-5334
Advisory CommitteeCardiovascular
Expedited ReviewNo
Combination Product Yes
Applicant Address LUTONIX 9409 Science Center Drive new Hope, MN 55428
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P170003Original Filing
S025 2021-11-18 30-day Notice
S024
S023 2021-07-06 30-day Notice
S022
S021 2021-03-08 Real-time Process
S020
S019
S018 2020-04-13 30-day Notice
S017
S016 2020-01-21 Real-time Process
S015 2019-11-25 30-day Notice
S014 2019-10-03 Normal 180 Day Track No User Fee
S013
S012 2019-09-18 Special (immediate Track)
S011
S010
S009
S008 2019-04-25 Normal 180 Day Track No User Fee
S007
S006 2019-02-26 Real-time Process
S005
S004 2018-10-04 Real-time Process
S003 2018-06-20 30-day Notice
S002 2018-05-18 Special (immediate Track)
S001 2017-09-25 Normal 180 Day Track No User Fee

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.